Dr Adam Rolt
Adam is a senior scientist within the complex medicines group at MDC. Following a PhD in Chemistry, he carried out postdoctoral positions at the NIH and the University of Oxford, where he was awarded a fellowship and transitioned into a molecular biology role. At MDC, Adam is responsible for the development of novel phenotypic assay […]
Dr Malcolm Haddrick
Malcolm is a Lead Scientist at MDC with 20+ years of experience in diverse Drug Discovery projects for efficacy and safety targets working at Pfizer and AstraZeneca. Malcolm has a PhD from the University of Leicester, followed by a postdoctoral position at the NIH in the USA studying HIV-1 pathogenesis. At MDC, his current role […]
John Vincent
John is a senior scientist with more than 25 years of experience in drug discovery roles, developing biochemical and cellular assays in a range of technologies and formats, utilising an array of laboratory equipment and automation. John has a degree from the University of Nottingham and previously worked for 23 years at AstraZeneca in roles […]
Dr Lorna Fitzpatrick
Lorna is a Lead scientist with over ten years’ of experience in molecular biology and genetic engineering in primary, stem and cancer cells. Lorna has a PhD from St. George’s University of London and carried out post-doctoral research at Manchester Metropolitan University before joining Medicines Discovery Catapult. In her current role, Lorna develops reporter models […]
Dr Emily Offer
Emily has 20 years’ experience in cell and molecular biology applied to drug discovery. Emily’s academic research involved the development and validation of stem cell derived models of disease and has subsequently led teams in large global pharma and biotech companies, developing cellular assays for both screening and phenotypic analysis of large and small molecule […]